| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered
|
蔡政芳;Tsai, Cheng-Fang |
| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis
|
Hua, Ssu-Ming;Huang, Ssu-Ming;蔡政芳;Tsai, Cheng-Fang;Chen, Dar-Ren;Chen, Dar-Ren;Wan, Min-Ying;Wang, Min-Ying;Yeh, Wei-Lan;Yeh, Wei-Lan |
| 國家衛生研究院 |
2018-12 |
p53 is sequestered by mitochondrial chaperone Lon in the matrix to restrain apoptosis under oxidative stress
|
Sung, YJ;Lee, YL |
| 國立成功大學 |
2013-02-15 |
p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells
|
Huang, Shi-Wei; Wu, Chun-Ying; Wang, Yen-Ting; Kao, Jun-Kai; Lin, Chi-Chen; Chang, Chia-Che; Mu, Szu-Wei; Chen, Yu-Yu; Chiu, Husan-Wen; Chang, Chuan-Hsun; Liang, Shu-Mei; Chen, Yi-Ju; Huang, Jau-Ling; Shieh, Jeng-Jer |
| 國立臺灣大學 |
1998 |
P53 Mutation in Advanced Stage of Primary Myelodysplastic Syndrome
|
唐季祿; 田蕙芬; 陳耀昌; TANG, JIH-LUH; TIEN, HWEI-FANG; CHEN, YAO-CHANG |
| 臺大學術典藏 |
2021-07-03T03:36:01Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; PEI-JER CHEN; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:59:03Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
JIH-LUH TANG; Tien H.-F.; Lin M.-T.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-26T09:08:25Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; Chen P.-J.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-01-04T12:13:08Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
HWEI-FANG TIEN; Lin M.-T.; Tang J.-L.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2018-09-10T06:12:56Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn, R.M. and Zhang, Y.-J. and Wang, L.-Y. and Chen, C.-J. and Lee, P.-H. and Lee, C.-S. and Tsai, W.-Y. and Santella, R.M.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:43:22Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn R.M.; Zhang Y.-J.; Wang L.-Y.; Chen C.-J.; PO-HUANG LEE; Lee C.-S.; Tsai W.-Y.; Santella R.M.; Lunn R.M.;Zhang Y.-J.;Wang L.-Y.;Chen C.-J.;Po-Huang Lee;Lee C.-S.;Tsai W.-Y.;Santella R.M. |
| 國立暨南國際大學 |
2012 |
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
|
余長澤; Yu, CTR |
| 國立臺北護理健康大學 |
1993-11 |
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer
|
Esrig, D;Spruck, CH;Nichols, PW;Chaiwun, B;Steven, K;Groshen, S;Chen, S-C;Skinner, DG;Jones, PA;Cote, RJ |
| 國立臺灣大學 |
2004 |
P53 Overexpression and Mutation in Metaplastic Carcinoma of the Breast: Genetic Evidence for a Monoclonal Origin of Both the Carcinomatous and the Heterogeneous Sarcomatous Components
|
連晃駿; 林中梧; 毛翠蓮; 郭頌鑫; 蕭正祥; 黃俊升; LIEN, HUANG-CHUN; LIN, CHUNG-WU; MAO, TSUI-LIEN; KUO, SUNG-HSIN; HSIAO, CHENG-HSIANG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2004-10 |
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, HC; Lin, CW; Mao, TL; Kuo, SH; Hsiao, CH; Huang, CS: |
| 臺大學術典藏 |
2018-09-10T04:46:16Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, H.-C. and Lin, C.-W. and Mao, T.-L. and Kuo, S.-H. and Hsiao, C.-H. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHUNG-WU LIN; HUANG-CHUN LIEN |
| 臺大學術典藏 |
2020-03-03T03:36:54Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Chung-Wu Lin;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; CHUNG-WU LIN; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-05T05:51:25Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Huang-Chun Lien;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; HUANG-CHUN LIEN; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-07T06:48:26Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Tsui-Lien Mao;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:35Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Chiun-Sheng Huang; Lien H.-C.; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-05T12:32:57Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:44Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Sung-Hsin Kuo;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; Mao T.-L.; SUNG-HSIN KUO; Hsiao C.-H.; Huang C.-S. |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 臺大學術典藏 |
2020-04-28T07:25:39Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Chih-Hung Hsu;Yeh K.-H.;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; CHIH-HUNG HSU; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:53Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Wang S.-M.;Chang K.-J.; Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-01-14T03:09:20Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-05-03T02:21:22Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
JIN-TUNG LIANG; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2022-08-12T06:28:26Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; KING-JEN CHANG |
| 高雄醫學大學 |
2011 |
p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock.
|
Tang, X;O'Reilly, A;Asano, M;Merrill, JC;橫山一成;Amar, S. ; Tang, X;O'Reilly, A;Asano, M;Merrill, JC;Yokoyama, KK;Amar, S. |
| 臺北醫學大學 |
1998 |
p53 point mutation enhanced by hepatic regeneration in aflatoxin B1-induced rat liver tumors and preneoplastic lesions.
|
朱娟秀; Lee CC; Liu JY; Lin JK; Chu JS and Shew JY |
| 亞洲大學 |
2011 |
p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through regulating miRNAs
|
;Liu, M.;Chen, C-T.;Yu, D.;洪明奇;Hung, Mien-Chie |
| 國立臺灣大學 |
2016 |
p53 及 ΔNp63α 對 CTEN 基因表現的調控
|
陳雅琪; Chen, Ya-chi |
| 國立成功大學 |
2022-07-29 |
p53 和 Sp1 在雌激素調控的肺癌發展所扮演之角色
|
陳詠晴; Chen, Yung-Ching |
| 中山醫學大學 |
2010 |
p53 失去活性轉錄活化 Nrf2 轉錄表現促進肺腫瘤發展以及患者有較差疾病復發之存活率
|
林伯霖; Po-Lin,Lin |
| 國立成功大學 |
2003 |
p53 相關蛋白WOX1 在神經發育與傷害病變中扮演的角色
|
陳淑姿; 張文粲 |
| 高雄醫學大學 |
2008 |
p53 與 X-ray Repair Cross-complementing Group 1 基因多型性在攝護腺癌接收攝護腺根除手術後PSA復發的預後角色
|
黃書彬;黃昭淵;王志生;劉家駒;蒲永孝;余宏政;余家政;吳東霖;黃俊雄;吳文正;周以和;吳明蒼 |
| 高雄醫學大學 |
2008 |
p53 與 X-ray Repair Cross-complementing Group 1 基因多型性在攝護腺癌接收攝護腺根除手術後PSA復發的預後角色
|
黃書彬;黃昭淵;王志生;劉家駒;蒲永孝;余宏政;余家政;吳東霖;黃俊雄;吳文正;周以和;吳明蒼 |
| 高雄醫學大學 |
2008 |
p53 與 X-ray Repair Cross-complementing Group 1 基因多型性在攝護腺癌接收攝護腺根除手術後PSA復發的預後角色
|
黃書彬;黃昭淵;王志生;劉家駒;蒲永孝;余宏政;余家政;吳東霖;黃俊雄;吳文正;周以和;吳明蒼 |
| 高雄醫學大學 |
2008 |
p53 與 X-ray Repair Cross-complementing Group 1 基因多型性在攝護腺癌接收攝護腺根除手術後PSA復發的預後角色
|
黃書彬;黃昭淵;王志生;劉家駒;蒲永孝;余宏政;余家政;吳東霖;黃俊雄;吳文正;周以和;吳明蒼 |
| 中國醫藥大學 |
1999 |
p53 表現碼72 之多形性與肺癌病人的化學治療抗藥性之相關性; Relationship between p53 codon 72 polymorphism and chemoresistance in lung cancer patients
|
夏德椿; Te-Chun Hsia |
| 慈濟大學 |
2014 |
p53 透過抑制 EBNA2主導的潛伏期感染相關的轉錄作用作為宿主抵抗EB病毒的感染策略
|
陳怜志 |
| 國立臺灣大學 |
2000 |
P53, P21 和 MDM2 蛋白及增殖細胞核抗原 (PCNA) 於齒源性囊腫之表現
|
江俊斌 |
| 臺大學術典藏 |
2018-09-10T18:06:30Z |
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment
|
MIN-HSIUNG PAN;Wang, Y.-J.;Ho, Y.-S.;Chen, H.-M.;Pan, M.-H.;Way, T.-D.;Ho, C.-T.;Wu, P.-H.;Chen, R.-J.; Chen, R.-J.; Wu, P.-H.; Ho, C.-T.; Way, T.-D.; Pan, M.-H.; Chen, H.-M.; Ho, Y.-S.; Wang, Y.-J.; MIN-HSIUNG PAN |
| 亞洲大學 |
2017-08 |
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.
|
Wang, 陳容甄；Rong-Jane Chen；吳珮瑄；Pei-Hsuan Wu；何其儻；Chi-Tang Ho；魏宗德；Tzong-Der Way；潘敏雄；Min-Hsiung Pan；陳?敏；Hsiu-Min Chen；何元順；Yuan-Soon Ho；王應然；Ying-Jan |
| 國立成功大學 |
2017-12-29 |
P53-derived hybrid peptides induce apoptosis of synovial fibroblasts in the rheumatoid joint
|
Chen;Shih-Yao;Shiau;Ai-Li;Wu;Chao-Liang;Wang;Chrong-Reen |
| 國立成功大學 |
2012-08-31 |
p53-WWOX-TIAF1為腫瘤抑制軸心
|
周沛宜; Chou, Pei-Yi |
| 中國醫藥大學 |
2003-07 |
p53/14-3-3σ路徑在肝癌發生角色之探討
|
彭成元 |
| 臺北醫學大學 |
2014 |
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p-53-specific CD8+ T cell responses
|
Hardwick, NR;Carroll, M;Kaltcheva, TI;Qian, D;Lim, D;Leong, L;Chu, P;Kim, J;Joseph, C;Fakih, MG;Yen, Y;Espenschied, J;Ellenhorn, JD;Diamond, DJ;Chung, V |
| 慈濟大學 |
2010 |
p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer
|
Hsu, Nan-Yung;Wu, Jeng-Yuan;Liu, Xiyong;Yen, Yun;Chen, Chih-Yi;Chou, Ming-Chih;Lee, Huei;Cheng, Ya-Wen |
